|Year||# Div.||Div. Paid||Div. Yield||Jan||Feb||Mar||Apr||May||Jun||Jul||Aug||Sep||Oct||Nov||Dec|
Rohto Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company offers eye care products, such as eye drops, care for contact lenses, and eye wash; facial care products comprising face wash, lotions, and creams; medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; and non-prescription medicines. It also operates beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co., Ltd. in 1949. Rohto Pharmaceutical Co., Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
The current Price to Earnings Ratio of Rohto Pharmaceutical is 22.6.
The PE Ratio is calcluated by dividing the current Rohto Pharmaceutical share price (30.10 USD) by the earnings per share (1.3).
The current Dividend Yield of Rohto Pharmaceutical is 93.0%.
The current market cap of Rohto Pharmaceutical is 3.5 B USD.
The current stock price of Rohto Pharmaceutical is 30.10 USD.
The ISIN (International Securities Identification Number) of Rohto Pharmaceutical is JP3982400008.
The ticker symbol of Rohto Pharmaceutical is RPHCF.
The address of the Rohto Pharmaceutical HQ is 1-8-1, Tatsumi-nishi, 544-8666 Osaka.